ScinoPharm Taiwan Ltd Capital Reinvestment Ratio
ScinoPharm Taiwan Ltd capital reinvestment ratio. ScinoPharm Taiwan Ltd (1789) has a Capital Reinvestment Ratio of 0.42x as of March 2026, meaning it reinvests 0% of its operating cash flow (NT$199.47 Million) in capital expenditures (NT$83.34 Million). See 1789 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of ScinoPharm Taiwan Ltd (2007–2025)
Capital reinvestment ratio of ScinoPharm Taiwan Ltd from 2007 to 2025. This chart tracks ScinoPharm Taiwan Ltd's Capital Reinvestment Ratio across 19 annual periods. See 1789 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
ScinoPharm Taiwan Ltd Capital Reinvestment Ratio by Year (2007–2025)
ScinoPharm Taiwan Ltd capital reinvestment ratio by year from 2007 to 2025. For the full cash flow conversion analysis, see 1789 cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.49x | NT$597.11 Million | NT$291.29 Million | ▲ +26.9% |
| 2024 | 0.38x | NT$750.91 Million | NT$288.73 Million | ▼ -68.8% |
| 2023 | 1.23x | NT$231.13 Million | NT$284.71 Million | ▲ +281.2% |
| 2022 | 0.32x | NT$773.79 Million | NT$250.04 Million | ▼ -48.7% |
| 2021 | 0.63x | NT$509.82 Million | NT$321.32 Million | ▲ +225.7% |
| 2020 | 0.19x | NT$946.31 Million | NT$183.10 Million | ▲ +44.4% |
| 2019 | 0.13x | NT$788.95 Million | NT$105.70 Million | ▲ +29.9% |
| 2018 | 0.10x | NT$1.23 Billion | NT$127.05 Million | ▼ -75.6% |
| 2017 | 0.42x | NT$971.71 Million | NT$410.93 Million | ▲ +53.6% |
| 2016 | 0.28x | NT$1.67 Billion | NT$458.52 Million | ▼ -56.9% |
| 2015 | 0.64x | NT$1.04 Billion | NT$667.58 Million | ▼ -44.5% |
| 2014 | 1.15x | NT$888.29 Million | NT$1.02 Billion | ▼ -13.0% |
| 2013 | 1.32x | NT$939.47 Million | NT$1.24 Billion | ▲ +47.5% |
| 2012 | 0.90x | NT$981.55 Million | NT$881.19 Million | ▲ +43.4% |
| 2011 | 0.63x | NT$1.29 Billion | NT$810.14 Million | ▲ +141.4% |
| 2010 | 0.26x | NT$1.56 Billion | NT$405.62 Million | ▲ +75.9% |
| 2009 | 0.15x | NT$1.30 Billion | NT$191.28 Million | ▲ +43.4% |
| 2008 | 0.10x | NT$1.41 Billion | NT$144.62 Million | ▼ -37.3% |
| 2007 | 0.16x | NT$504.50 Million | NT$82.74 Million | — |